Protocols
1 protocol(s) meet the specified criteria
Drug: BRENTUXIMAB VEDOTIN
Protocol No.TitleStatus
E4412-CIRBA Phase I Study with an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin LymphomaOpen